Tag: daraxonrasib
-
Media Monitor: Pancreatic Cancer Drug Shows Promising Clinical Trial Results
The Washington Post is reporting that a new pill, daraxonrasib, has shown promising results in a clinical trial for pancreatic cancer, doubling patient survival compared to standard chemotherapy.
HealthScience & TechnologyMedical Science DaraxonrasibClinical trialPancreatic cancerChemotherapyMedical researchDrug developmentThe Washington Post